Upstream Processing

  1. Applying AI And Rapid Prototyping To Media And Process Development 3/26/2026

    Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.

  2. Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium 6/16/2025

    Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.

  3. Boost CHO Cell Protein Production By Up To 146% With Efficient-Pro™ Feed Solutions 4/15/2026

    Up to 146% higher protein titers in CHO-K1 culture. See how advanced feed technology and animal–origin–free formulations are redefining what consistent protein production looks like.

  4. Outsourcing Considerations For Novel Protein Therapeutics 9/13/2024

    Panelists discuss special considerations for outsourcing the development and manufacturing of novel, complex protein therapeutics in this Bioprocess Online Live event.

  5. Addressing Aggregation And Degradation In Complex Protein Therapeutics 9/13/2024

    In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, panelists discuss using a transient expression platform to make fast early product attribute decisions.

  6. Nunc Standard Closed Cell Factory System 2/2/2022

    This clean and closed system is designed to provide consistent and high-quality results to enhance your adherent cell culture processes. This ready-to-use system will help you quickly develop and scale up your processes with standard components for supply assurance.

  7. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.

  8. Five Reasons To Choose Thermo Scientific DynaDrive Single-Use Bioreactors 3/25/2026

    Explore five key advantages of single-use bioreactors, including scalable design, homogeneous mixing, broad chemical compatibility, and streamlined seed train processes for bioproduction success.

  9. CTS DynaCellect Cinematic Overview 6/2/2025

    Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.

  10. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.